Artwork
iconShare
 
Manage episode 522267588 series 3696680
Content provided by Drew Fallon. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drew Fallon or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this enlightening conversation, Drew Fallon speaks to Danny Yeung, CEO of Prenetics, who shares the journey of his entrepreneurial ventures, the pivot to at-home PCR testing during the COVID-19 pandemic, and the launch of IM8, a revolutionary supplement brand co-founded with David Beckham. He discusses the importance of science-backed formulations, customer acquisition strategies, and the company's focus on long-term growth. Additionally, Danny elaborates on Prenetics' capital market strategies, including a unique Bitcoin treasury approach, and shares his vision for the future of IM8 and Prenetics.

Chapters:

00:00 The Fastest-Growing Supplement Brand Ever?

00:25 From Restaurants to $200M E-Commerce

02:54 Scaling Groupon: CAC, LTV & Funnels

06:52 Why DTC Failed Early for Genetics

07:15 COVID Pivot: 28 Million PCR Tests

08:47 Revenue Rocket: $10M → $65M → $275M

13:05 Replacing $800M Revenue: Birth of IM8

14:11 Meeting Beckham & Co-Founding IM8

17:18 Clinical Doses, Mayo Clinic, and NSF Testing

23:29 $600K Month One → $10M Month Eleven

25:18 Sub-4-Month Payback: The Scaling Formula

31:47 Bitcoin Treasury & Divesting Legacy Units

  continue reading

9 episodes